Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
Authors:
- 1 April 1990
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 82 (S358) , 99-103
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophreniaActa Psychiatrica Scandinavica, 1988
- Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityActa Psychiatrica Scandinavica, 1986
- Sulpiride and Haloperidol in Schizophrenia: A Double-blind Cross-over Study of Therapeutic Effect, Side Effects and Plasma ConcentrationsThe British Journal of Psychiatry, 1985
- An open multicentre study of the treatment of florid schizophrenia with remoxiprideActa Psychiatrica Scandinavica, 1985
- An open study of remoxipride, a benzamide derivative, in schizophreniaPsychopharmacology, 1985
- Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brainEuropean Journal of Pharmacology, 1984
- Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activitiesJournal of Medicinal Chemistry, 1982
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970